收费全文 | 20753篇 |
免费 | 1219篇 |
国内免费 | 810篇 |
耳鼻咽喉 | 36篇 |
儿科学 | 331篇 |
妇产科学 | 142篇 |
基础医学 | 4127篇 |
口腔科学 | 211篇 |
临床医学 | 2152篇 |
内科学 | 3644篇 |
皮肤病学 | 309篇 |
神经病学 | 957篇 |
特种医学 | 404篇 |
外国民族医学 | 3篇 |
外科学 | 1105篇 |
综合类 | 3123篇 |
现状与发展 | 2篇 |
预防医学 | 894篇 |
眼科学 | 198篇 |
药学 | 3418篇 |
9篇 | |
中国医学 | 642篇 |
肿瘤学 | 1075篇 |
2024年 | 22篇 |
2023年 | 162篇 |
2022年 | 326篇 |
2021年 | 528篇 |
2020年 | 484篇 |
2019年 | 422篇 |
2018年 | 496篇 |
2017年 | 494篇 |
2016年 | 550篇 |
2015年 | 488篇 |
2014年 | 894篇 |
2013年 | 1526篇 |
2012年 | 872篇 |
2011年 | 994篇 |
2010年 | 782篇 |
2009年 | 721篇 |
2008年 | 795篇 |
2007年 | 857篇 |
2006年 | 796篇 |
2005年 | 778篇 |
2004年 | 738篇 |
2003年 | 703篇 |
2002年 | 614篇 |
2001年 | 531篇 |
2000年 | 549篇 |
1999年 | 475篇 |
1998年 | 458篇 |
1997年 | 472篇 |
1996年 | 487篇 |
1995年 | 466篇 |
1994年 | 463篇 |
1993年 | 402篇 |
1992年 | 420篇 |
1991年 | 388篇 |
1990年 | 344篇 |
1989年 | 286篇 |
1988年 | 277篇 |
1987年 | 231篇 |
1986年 | 192篇 |
1985年 | 375篇 |
1984年 | 319篇 |
1983年 | 164篇 |
1982年 | 147篇 |
1981年 | 74篇 |
1980年 | 60篇 |
1979年 | 28篇 |
1978年 | 34篇 |
1977年 | 28篇 |
1976年 | 20篇 |
1974年 | 16篇 |
Introduction
Type 1 diabetes mellitus (T1DM) is a chronic, autoimmune disease that is characterized by total absence of insulin production. Hypertension is a common comorbidity in T1DM with complex pathophysiology, while it is also a well-recognized risk factor for the development of cardiovascular disease (CVD), as well as other microvascular diabetic complications. 相似文献Objective
To assay peripheral inter-ictal cytokine serum levels and possible relations with non-invasive vagus nerve stimulation (nVNS) responsiveness in migraineurs.Methods
This double-blinded, sham-controlled study enrolled 48 subjects and measured headache severity, frequency [headache days/month, number of total and mild/moderate/severe classified attacks/month], functional state [sleep, mood, body weight, migraine-associated disability] and serum levels of inflammatory markers [inter-ictal] using enzyme-linked immunoassays at baseline and after 2 months of adjunctive nVNS compared to sham stimulation and suitably matched controls.Results
No significant differences were observed at baseline and after 2 months for headache severity, total attacks/month, headache days/month and functional outcome [sleep, mood, disability] between verum and sham nVNS. However, the number of severe attacks/month significantly decreased in the verum nVNS group and circulating pro-inflammatory IL-1β was elevated significantly in the sham group compared to nVNS. Levels of anti-inflammatory IL-10 were significantly higher at baseline in both groups compared to healthy controls, but not at 2 months follow-up [p?<?0.05]. Concentrations of high-mobility group box-1 (HMGB-1), IL-6, tumor-necrosis factor-α (TNF-α), leptin, adiponectin, ghrelin remained unchanged [p?>?0.05]. No severe device-/stimulation-related adverse events occurred.Conclusion
2 months of adjunctive cervical nVNS significantly declined the number of severe attacks/month. Pro-inflammatory IL-1β plasma levels [inter-ictal] were higher in sham-treated migraine patients compared to verum nVNS. However, pro- [IL-6, HMGB-1, TNF-α, leptin] and anti-inflammatory [IL-10, adiponectin, ghrelin] mediators did not differ statistically. Profiling of neuroinflammatory circuits in migraine to predict nVNS responsiveness remains an experimental approach, which may be biased by pre-analytic variables warranting large-scale biobank-based systematic investigations [omics]. 相似文献Butyrylcholinesterase (BChE) is a serine esterase that plays a role in the detoxification of natural as well as synthetic ester-bond-containing compounds. Alterations in BChE activity are associated with a number of diseases. Cholinergic system abnormalities in particular are correlated with the formation of senile plaques in Alzheimer’s disease (AD), and administration of cholinesterase inhibitors is a common therapeutic approach used to treat AD.
Here, our aim was to study the interaction between BChE and fluoxetine.
Molecular docking simulations revealed that fluoxetine penetrated deep into the active-site gorge of BChE and that it was engaged in stabilizing noncovalent interactions with multiple subsites. In substrate kinetic studies, the Vm, Km, kcat and kcat/Km values were found to be 20.59?±?0.36?U mg?1 protein, 194?±?14?µM, 1.3?×?108?s?1 and 6.7?×?105?µM?1s?1, respectively. Based on inhibitory studies, fluoxetine appeared to inhibit BChE competitively, with an IC50 value of 104?µM and a Ki value of 36.3?±?4.7?µM.
Overall, both the low Ki value and the high number of BChE–fluoxetine interactions suggest that fluoxetine is a potent inhibitor of BChE, although in vivo mechanisms for the direct effects of BChE inhibition on various pathologies remain to be further investigated.